Port needles: do they need to be removed as frequently in infusional chemotherapy?

J Infus Nurs

Outpatient Chemotherapy Unit, Marmara University Hospital, Tophanelioglu C, 13/15 Altunizade, Uskudar, 81190 Istanbul, Turkey.

Published: September 2003

Protracted chemotherapy regimens are new treatment modalities used to treat patients with cancer. These treatments are preferred because of the ease of administration and limited side effects in the outpatient setting. Sixty patients were treated with continuous infusion chemotherapy via implanted infusion ports at Marmara University Hospital Outpatient Chemotherapy Unit in Istanbul, Turkey, from January 2000 to December 2001. Although usage of Huber needles for central venous catheters was limited to between 48 and 72 hours, needles were not removed unless there were signs of inflammatory reaction. The needles remained in place for 28 days (1-49 days) on average. No catheter infections, signs of local irritation, or thrombus formation were observed despite prolonged stay of the Huber needles. Huber needles can be left in place up to several weeks without any untoward effects as long as proper aseptic technique is used.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00129804-200307000-00009DOI Listing

Publication Analysis

Top Keywords

huber needles
12
needles removed
8
needles
5
port needles
4
removed frequently
4
frequently infusional
4
infusional chemotherapy?
4
chemotherapy? protracted
4
protracted chemotherapy
4
chemotherapy regimens
4

Similar Publications

Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies.

Eur Urol Oncol

February 2025

Department of Biomedical Engineering, Yale University New Haven CT USA; Department of Radiology and Biomedical Imaging, Yale University New Haven CT USA; Department of Urology, Yale University New Haven CT USA. Electronic address:

Background And Objective: Conventional core needle biopsy for prostate cancer diagnosis can lead to diagnostic uncertainty and complications, prompting exploration of alternative risk assessment approaches that use clinical and imaging features. Our aim was to evaluate the effectiveness of machine learning (ML) models in reducing unnecessary biopsies.

Methods: We conducted a retrospective analysis of data for 1884 patients across two academic centers who underwent prostate magnetic resonance imaging and biopsy between 2016 and 2020 or 2004 and 2011.

View Article and Find Full Text PDF
Article Synopsis
  • Thyroid radiofrequency ablation (RFA) is a minimally invasive procedure used to treat benign thyroid nodules, offering an alternative to surgery or radioactive iodine with minimal risks and side effects.
  • RFA shows a high efficacy, achieving a volume reduction of 67 to 75% in nodules within a year.
  • The article also discusses thyroid artery embolization, another emerging technique for reducing nodule size in certain patients, particularly those unsuitable for surgery.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess how effective contrast-enhanced ultrasound (CEUS)-guided biopsies are for diagnosing retroperitoneal masses (RMs).
  • Over a 17-year period, 87 patients underwent this procedure, with successful biopsies in 96.6% of cases and solid tissue obtained in all solid tumor samples.
  • The findings indicate that CEUS-guided biopsies are both safe and highly accurate, showing a 94.2% overall diagnostic accuracy for distinguishing between malignant and benign RMs, with a minimal complication rate.
View Article and Find Full Text PDF
Article Synopsis
  • Pneumothorax (PTX) is a rare but serious condition in neonates, with an overall incidence of 0.56 per 100 births, varying between hospitals; treatment methods included conservative care, chest tube drainage, and needle aspiration.
  • Among the treatment options, needle aspiration had a higher failure rate (37%) compared to chest tube drainage (9%), yet it resulted in fewer X-rays and shorter hospital stays (2 days vs 6 days).
  • The study proposes a new management algorithm to standardize PTX treatment across different hospitals in the network, aiming to improve outcomes while considering the variability of incidence rates.
View Article and Find Full Text PDF

Background: Totally implantable venous access port (TIVAP) is a type of implantable medical device that enables repetitive access to the intravenous system through use of a Huber needle. This device facilitates the administration of aggressive or long-term treatments while ensuring the comfort and safety of the patient. To ensure proper use of the medical device and lower the risk of complications, it is essential that patients acquire the necessary knowledge and skills regarding TIVAP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!